Cargando…

Virus-host interactomics: new insights and opportunities for antiviral drug discovery

The current therapeutic arsenal against viral infections remains limited, with often poor efficacy and incomplete coverage, and appears inadequate to face the emergence of drug resistance. Our understanding of viral biology and pathophysiology and our ability to develop a more effective antiviral ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Chassey, Benoît, Meyniel-Schicklin, Laurène, Vonderscher, Jacky, André, Patrice, Lotteau, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4295275/ https://www.ncbi.nlm.nih.gov/pubmed/25593595 http://dx.doi.org/10.1186/s13073-014-0115-1

Ejemplares similares

Viruses and Interactomes in Translation
por: Meyniel-Schicklin, Laurène, et al.
Publicado: (2012)

The Interactomes of Influenza Virus NS1 and NS2 Proteins Identify New Host Factors and Provide Insights for ADAR1 Playing a Supportive Role in Virus Replication
por: de Chassey, Benoît, et al.
Publicado: (2013)

VirHostNet: a knowledge base for the management and the analysis of proteome-wide virus–host interaction networks
por: Navratil, Vincent, et al.
Publicado: (2009)

Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy
por: Pila-Castellanos, Irene, et al.
Publicado: (2021)

Correction: Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy
por: Pila-Castellanos, Irene, et al.
Publicado: (2021)

Virus–host interactomes — antiviral drug discovery
por: Ma-Lauer, Yue, et al.
Publicado: (2012)

pISTil: a pipeline for yeast two-hybrid Interaction Sequence Tags identification and analysis
por: Pellet, Johann, et al.
Publicado: (2009)

Flavivirus NS3 and NS5 proteins interaction network: a high-throughput yeast two-hybrid screen
por: Le Breton, Marc, et al.
Publicado: (2011)

When the human viral infectome and diseasome networks collide: towards a systems biology platform for the aetiology of human diseases
por: Navratil, Vincent, et al.
Publicado: (2011)

The host interactome of influenza virus presents new potential targets for antiviral drugs
por: Shaw, Megan L.
Publicado: (2011)

An anti-diabetic drug targets NEET (CISD) proteins through destabilization of their [2Fe-2S] clusters
por: Marjault, Henri-Baptiste, et al.
Publicado: (2022)

Comparison of viral RNA–host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2
por: Zhang, Shaojun, et al.
Publicado: (2021)

IRGM Is a Common Target of RNA Viruses that Subvert the Autophagy Network
por: Grégoire, Isabel Pombo, et al.
Publicado: (2011)

CREDO: a structural interactomics database for drug discovery
por: Schreyer, Adrian M., et al.
Publicado: (2013)

New therapeutic modalities in drug discovery and development: Insights & opportunities
por: Kansy, Manfred, et al.
Publicado: (2021)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Characterization and functional interrogation of the SARS-CoV-2 RNA interactome
por: Labeau, Athéna, et al.
Publicado: (2022)

Mitochondrial Interactome: A Focus on Antiviral Signaling Pathways
por: Refolo, Giulia, et al.
Publicado: (2020)

The current landscape of coronavirus-host protein–protein interactions
por: Perrin-Cocon, Laure, et al.
Publicado: (2020)

Functionalised Cofactor Mimics for Interactome Discovery and Beyond
por: Wilkinson, Isabel V. L., et al.
Publicado: (2022)

Insight into the Mammalian Aquaporin Interactome
por: Törnroth-Horsefield, Susanna, et al.
Publicado: (2022)

Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016)

Recommender Systems in Antiviral Drug Discovery
por: Sosnina, Ekaterina A., et al.
Publicado: (2020)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
por: Sadegh, Sepideh, et al.
Publicado: (2020)

The Domain Landscape of Virus-Host Interactomes
por: Zheng, Lu-Lu, et al.
Publicado: (2014)

Computational Analysis of Virus–Host Interactomes
por: Friedel, Caroline C.
Publicado: (2013)

Opportunities and Risks of Host-targeting Antiviral Strategies for Hepatitis C
por: Gerold, Gisa, et al.
Publicado: (2013)

Severe fever with thrombocytopenia syndrome virus (SFTSV)-host interactome screen identifies viral nucleoprotein-associated host factors as potential antiviral targets
por: Cao, Jianli, et al.
Publicado: (2021)

Discovery of Antivirals Using Phage Display
por: Sokullu, Esen, et al.
Publicado: (2021)

Hepatitis C Lipo-Viro-Particle from Chronically Infected Patients Interferes with TLR4 Signaling in Dendritic Cell
por: Agaugué, Sophie, et al.
Publicado: (2007)

Norovirus: Targets and tools in antiviral drug discovery
por: Rocha-Pereira, Joana, et al.
Publicado: (2014)

Functional genomics in virology and antiviral drug discovery
por: DeFilippis, Victor, et al.
Publicado: (2003)

A phenomics approach for antiviral drug discovery
por: Rietdijk, Jonne, et al.
Publicado: (2021)

Xenopus Meiotic Microtubule-Associated Interactome
por: Gache, Vincent, et al.
Publicado: (2010)

Computational Studies of the Intestinal Host-Microbiota Interactome
por: Christley, Scott, et al.
Publicado: (2015)

Deubiquitylating enzymes and drug discovery: emerging opportunities
por: Harrigan, Jeanine A., et al.
Publicado: (2017)

Natural products in drug discovery: advances and opportunities
por: Atanasov, Atanas G., et al.
Publicado: (2021)

An Update on CFTR Drug Discovery: Opportunities and Challenges
por: D’Ursi, Pasqualina, et al.
Publicado: (2022)

AI in drug discovery: Applications, opportunities, and challenges
por: Bittner, Martin-Immanuel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e1jur63kq0dr236caog1jfglso